OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
Sign Up to like & getrecommendations! Published in 2019 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2019.08.009
Abstract: OBJECTIVES Our aim was to investigate the prevalence and potential risk factors for persistent and troublesome physical and psychological symptoms following treatment for ovarian cancer (OC). METHODS OvQuest is an international, internet-based, cross-sectional questionnaire which… read more here.
Keywords: diagnosis; treatment; ovarian cancer; life ... See more keywords
Niraparib for the treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2018.1490180
Abstract: ABSTRACT Introduction: Niraparib, an orally available selective inhibitor of poly(adenosine diphosphate-ribose) polymerase (PARP), is the first PARP inhibitor approved for use in patients with ovarian cancer who do not harbor a germ-line or somatic mutation… read more here.
Keywords: cancer; ovarian cancer; niraparib treatment; treatment ovarian ... See more keywords
The safety of bevazicumab for the treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1532500
Abstract: ABSTRACT Introduction: The safety profile of bevacizumab (BV) remains a challenging issue, in particular its role in fragile OC patients. Areas covered: In this literature review, we have analyzed safety data from Phase III trials… read more here.
Keywords: safety; drug; ovarian cancer; bevazicumab treatment ... See more keywords
Abstract A44: A CRISPRi screen to identify combination therapies for improved treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.ovca19-a44
Abstract: Ovarian cancer is the fifth leading cause of cancer death for women in the United States, with only modest improvements in patient survival in the past few decades. Standard-of-care treatment is surgical debulking followed by… read more here.
Keywords: combination; screen; ovarian cancer; cancer ... See more keywords
Artificial colloids versus human albumin for the treatment of ovarian hyperstimulation syndrome: A retrospective cohort study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Reproductive Biomedicine"
DOI: 10.18502/ijrm.v17i10.5287
Abstract: Background The optimal colloid solution for the treatment of ovarian hyperstimulation syndrome (OHSS) remains to be established. Objective We aimed to compare artificial colloids (AC) with human albumin (HA) for the treatment of OHSS. Materials… read more here.
Keywords: ovarian hyperstimulation; treatment; artificial colloids; hyperstimulation syndrome ... See more keywords
BRCA mutations in the manifestation and treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18280
Abstract: BRCA genes are important for the integrity and stability of genetic material and play key roles in repairing DNA breaks via high fidelity homologous recombination. BRCA mutations are known to predispose carriers to gynecological malignancies,… read more here.
Keywords: treatment; brca mutations; manifestation treatment; mutations manifestation ... See more keywords
Computable structured aptamer for targeted treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2023.1170260
Abstract: Nucleolin protein expression is higher on the ovarian cancer cell surface. AS1411, a DNA aptamer, can bind with nucleolin protein specifically. In this study, we developed HA and ST DNA tiles to assemble six AS1411… read more here.
Keywords: computable structured; ovarian cancer; treatment ovarian; cancer ... See more keywords
Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.820128
Abstract: Ovarian cancer remains the leading cause of death from gynecological cancer. Survival is significantly related to the stage of the disease at diagnosis. Of quite importance is primary cytoreductive surgery, having as a goal to… read more here.
Keywords: neoadjuvant treatment; cancer new; ovarian cancer; treatment ovarian ... See more keywords
Peptides for diagnosis and treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1135523
Abstract: Ovarian cancer is the most deadly gynecologic malignancy, and its incidence is gradually increasing. Despite improvements after treatment, the results are unsatisfactory and survival rates are relatively low. Therefore, early diagnosis and effective treatment remain… read more here.
Keywords: diagnosis treatment; ovarian cancer; peptides diagnosis; treatment ovarian ... See more keywords